Cerebral cavernous angiomas malformations (CCM) can be inherited as an autosomal dominant condition. CCM1, a yet unidentified gene mapping on 7q21-q22, was shown to be involved in all CCM Hispano-American families, with a strong founder effect. Genetic heterogeneity in non Hispano-American families was established in two families.
Introduction
Cavernomas are abnormally enlarged capillary cavities without intervening brain parenchyma. Main clinical symptoms include seizures, cerebral haemorrhage, headache and focal neurological deficits. They may occur with an autosomal dominant pattern of inheritance. 1 In 1995, in a large Hispano-American family, Dubovsky et al 2 mapped a gene, CCM1, to chromosome 7q, within a 33 cM interval. This genetic mapping was further confirmed in a large number of HispanoAmerican families and a strong founder effect was observed in that ethnic group. [3] [4] [5] [6] [7] The size of the genetic interval likely to contain CCM1 was reduced to 4 cM, between markers D7S2410 and D7S689. 5 Only eight non Hispano-American families have been analysed so far. 4, 5, [8] [9] [10] Two of them were not linked to CCM1, establishing the genetic heterogeneity of this condition. 9 We report linkage data on 36 French Caucasian CCM families using a panel of eight polymorphic microsatellite markers mapping within the D7S2410-D7S689 interval.
Material and methods
We selected 36 French families for genotyping ( Figure 1) . Clinical, neuroimaging features and status criterias were detailed elsewhere. 10, 11 All families were Caucasian and originated from France. A total of 220 potentially informative meioses, including 157 affected individuals, were analysed.
Seven polymorphic microsatellites spanning the CCM1 interval (D7S2410, D7S2409, D7S646, D7S689, D7S1813, D7S1789, D7S558) were chosen from the Généthon linkage map 12 and from the Cooperative Human Linkage Center. M65B was identified by SL, based on sequencing data of a Linkage analysis was performed as previously described. 10 Parameters for linkage analysis were based on a combination of epidemiological 13 and clinical/Magnetic Resonnance Imaging (MRI) data from the French CCM families. 11 Briefly, large autopsies and MRI series estimated the prevalence of cavernous angiomas in the general population to be close to 0.5-1%. 13 In the French population, 10-20% of these cavernous angiomas are hereditary (ETL, unpublished results). The penetrance was estimated to be close to 90% when MRI was used to establish the status. 11 Therefore linkage parameters were established as follows: phenocopy prevalence of 0.01, gene frequency of 0.001 and 90% penetrance.
Multilocus analysis of the four most informative markers (D7S2410, M65B, D7S646 and D7S689) was computed after recoding each marker to a three alleles system which did not change significantly the results of the two-point analysis for any of the latter markers. Genetic linkage analysis of a subset of CEPH families and of our families, as well as physical mapping data, 12 (SL, unpublished results) strongly suggest that the most likely order of markers used for multipoint linkage analysis is D7S2410-(0.03)-M65B-(0.005)-D7S646-(0.005)-D7S689. Homogeneity was assessed using the admixture test implemented in the HOMOG program package.
Results
Significant lod scores were obtained for family 25 with several markers (Table 1) . Lod scores higher than 1 were obtained in eight additional families (families 3,9,10,13,23,27,35,40) with at least two markers. Negative lod scores values < -2 were obtained for four families (families 2, 20, 39, 49).
HOMOG admixture analyses of multipoint data are shown in Table 2 . The percentage of families linked to CCM1 was estimated to be close to 65%. Nine families displayed a conditional probability PP to be linked to the CCM1 locus above 0.95 and four families had a PP < 0.1%.
Analysis of the CCM1 haplotypes of the nine families having a conditional probability to be linked > 95% showed that none of these families shared the HispanoAmerican haplotype (Figure 2) . Some alleles such as M65B-133bp were frequent but there was no significant difference of frequency when compared with our control population (spouses and unlinked haplotypes) using the p-excess methodology. 6 Comparative analysis of the nine linked haplotypes (Figure 2 ) did not show evidence for a founder effect.
Four recombinant events were observed within the nine linked families. Three of them were observed in healthy individuals having a normal MRI and aged 35 and 33 years old (F9*, F9**) and 56 years old (F23*). F* was recombinant at D7S2410 and carried the 'healthy' alleles for the other markers. F9** carried the whole affected haplotype due either to a double recombination event within the CCM1 interval or to the incomplete penetrance of this condition. F23* was recombinant with D7S2410 and was no more recombinant with telomeric markers. In family F27, a recombination event also occurred with marker D7S2410 within an affected individual: affected individuals belonging to two of the three branches of this family did not share any allele for this marker. No other recombination event was detectable in this family. 
Conclusion
Herein we confirmed the genetic heterogeneity of this condition and showed that CCM1 is the main locus in the French population, the proportion of families linked to chromosome 7 being close to 65%. Haplotypes analysis within linked families did not support the existence of a strong founder effect. Analysis of these families as well as of additional families with new microsatellite markers mapping within the CCM1 interval is needed to refine this interval further. It will be a crucial step for the identification of the CCM1 gene, since no strong candidate has yet been mapped within the interval. 
